The Appetite Revolution
How Protein has become the next profit engine for restaurants
Something subtle is reshaping the landscape of modern dining, not just a trend, but a physiological shift. Across North America, appetites are changing. People are eating less, but thinking more carefully about what they consume. The rise of GLP-1 medications like Ozempic and Wegovy has begun to redefine not just waistlines, but business models.
The implications for the food and beverage industry are immense: fewer calories, but higher expectations. The next era of eating will not be defined by indulgence, but by intention. Indeed, there is a unique opportunity for restaurants and food service operators to monetize on this once in a lifetime opportunity
By way of example; step into a Starbucks and you’ll see that future already taking form. Behind the familiar hum of espresso machines and the comforting swirl of seasonal flavors, a quiet transformation is underway. Protein has moved from the sidelines to center stage. Shakes, lattes, and cold brews now boast up to 30 grams of protein, engineered to satisfy not just taste, but nutrition. These drinks look indulgent and taste familiar, yet they speak to an entirely new purpose.
It isn’t coincidence; it’s foresight. Starbucks has recognized that the next chapter of appetite will be smaller, denser, and fueled by protein, a preview of the food economy to come.
We are entering what I call ‘The Appetite Revolution’: a fundamental shift in how many people consume food, how restaurants design menus, and how profit will be made in the next decade. The engine of this nuanced transformation is a pharmaceutical breakthrough, the rise of GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, and the nutritional response to them.
These drugs, originally developed to treat diabetes, have now become powerful tools for weight management. They suppress appetite, slow digestion, and alter the way people experience hunger. Millions of people are already using them, and with the arrival of lower-cost generic versions in 2026, access will expand exponentially. That expansion will change the way the world eats, and, by extension, the way restaurants must think.
These developments are compounded by, soon to launch, advanced weight-loss drugs like Orforglipron, Retatrutide, and MariTide which are in development to replace Ozempic, Wegovy, and Mounjaro. These drugs offer potential advantages such as oral administration, higher efficacy, and the ability to maintain weight loss after treatment ends. In. other words, the market has many expansion trigger points that will accelerate the opportunity over the next few years.
The most immediate impact of GLP-1 use is that people eat less, sometimes far less. Meals shrink, snacking decreases, and portion sizes that once felt normal now feel excessive. Yet nutritional requirements remain the same. Humans still need their vitamins, minerals, and especially protein to preserve muscle and maintain energy. The result is an entirely new consumer behaviour: a demand for maximum nutrition in minimal volume.
For restaurant operators, this is not a problem, it’s a profit opportunity. Smaller portions served at the same or slightly higher prices translate directly into higher margins. When a guest orders a smaller entrée or protein-dense latte instead of a full meal, the operator’s cost base drops, but the perceived value, health, wellness, performance, goes up. It’s a rare economic moment where doing less yields more.
Coffee shops were the first to spot the opportunity because beverages are the easiest way to deliver nutrition without challenging appetite. A protein-infused cold brew doesn’t feel like a diet drink, it feels like an upgrade. Starbucks and Tim Hortons were early movers, quickly followed by Smoothie King, which launched a “GLP-1 Support Menu” offering high-protein, low-sugar smoothies for customers taking appetite-suppressing medications.
Even traditional bakery cafés are beginning to pivot. Panera and Pret a Manger have been quietly re-engineering their menus around protein-forward bowls and smoothies. A Pret location in New York now offers a “Protein Power Smoothie” with 28 grams of protein, a decade ago, such a drink would have been confined to a gym, not a café counter
.
These brands aren’t selling supplements. They’re selling solutions to a new biological reality: the customer can’t eat as much but still needs to nourish themselves.
Full-service restaurants have been slower to react, partly because their model is built on volume, bigger plates, multi-course meals, the ritual of dining out. But that model begins to falter when diners physically can’t finish what’s served. Over the next few years, operators will have to redesign portion sizes, rethink value perception, and pivot toward smaller, protein-centric dishes that still feel generous in experience.
Some have already begun. Noodles & Company, for example, introduced new bowls that deliver higher protein per calorie, and allows customers to add extra chicken or tofu in half-portions. Snooze A.M. Eatery, a brunch chain, has quietly rolled out protein pancakes and egg-white scrambles that appeal to the same consumer base. And independents, those nimble enough to adapt quickly, are finding creative ways to make protein stylish rather than clinical.
In Los Angeles, cafés like Great White and Dialog are blending protein into smoothies and breakfast bowls without compromising on taste or aesthetics. In London, boutique chains such as Granger & Co and Joe & The Juice are experimenting with fortified drinks that align with the wellness lifestyles of their clientele.
For decades, restaurant profitability was tied to volume. The more you sold, the more you made. But as consumption declines, value shifts from quantity to quality, from abundance to efficiency. Protein is fast becoming the new luxury: an essential nutrient that signals care, health, and premium craftsmanship.
The economics are elegant. Protein-rich ingredients often carry higher perceived value than their actual cost contribution. A 4-ounce portion of grilled salmon or tofu can satisfy a customer on a GLP-1 medication who might once have ordered an 8-ounce steak. Charge the same price, serve half the weight, and deliver the same satisfaction, that’s a 20-30% increase in gross margin.
Restaurants that understand this are already redesigning for it. Smaller plates, protein-dense sauces, and portion-controlled menu options are becoming both operationally efficient and financially advantageous. The old obsession with “value for volume” is giving way to “value for nutrition.”
When you strip away the health buzzwords, what’s really happening is a fundamental shift in restaurant economics. For decades, operators equated value with portion size: bigger plates, bundled deals, “all you can eat.” But as appetites shrink, that model collapses.
Revenue Potential (USA)
If even 10 million Americans using GLP-1s dine out weekly and spend an average of $20 more for ‘GLP-1-friendly’ options, that’s an annual $10B domestic opportunity. Scale that globally, and the foodservice potential easily exceeds $25–30B.
Imagine an average entrée that used to cost $4 in ingredients and sold for $16. If that same dish becomes a half-portion with $2.50 in food cost but still commands $14, the gross margin jumps from 75% to 82%. Multiply that across a menu and the maths become transformative.
Restaurants that learn to tell the story, “right-sized portions, optimized nutrition”, will not only preserve perceived value but also unlock significant profit growth. The key is messaging: positioning smaller plates not as less food, but as smarter dining.
This isn’t a passing fad. It’s a long-term evolution of eating habits, the most significant since the rise of fast-casual dining. When generic GLP-1s hit the market in 2026, affordability will unlock mass adoption. Millions who couldn’t previously access these drugs will begin using them, and with that, their relationship with food will change almost overnight.
Those who dismiss the shift as a niche “diet trend” will find themselves losing relevance. Those who prepare, by redesigning menus, retraining staff, and recalibrating pricing, will capture a new class of loyal, high-margin customers.
The restaurant industry has always adapted to societal change, from the rise of delivery apps to the fall of sugar. But this is different. Appetite itself is changing. Consumers will no longer measure satisfaction by how much they eat, but by how well they eat.
For operators, that means opportunity. Smaller plates, premium pricing, lower waste, and stronger margins. For diners, it means meals that are more intentional, more efficient, and more aligned with their health goals.
Actionable Operational Shifts
The GLP-1 Menu Framework
To capitalize on the shift, restaurants must design GLP-1-responsive menus built around five principles:
1. Shrink Volume, Increase Density: halve portion size, double protein per ounce.
2. Add Fluid Nutrition: introduce protein lattes, broths, or meal replacement smoothies.
3. Simplify Macronutrient Messaging: icons like 🥩 High-Protein, 🌱 GLP-1 Friendly.
4. Offer Micro-Portions: small entrées, snack boards, and customizable bowls.
5. Flavor Without Excess: less sugar, more umami and natural sweetness.
And for those of us advising brands, it means reimagining what hospitality looks like when less truly becomes more.
About The Author:
Robert Ancill is a globally recognized restaurant consultant, design innovator, author, and trend forecaster. Based in Los Angeles and originally from Glasgow, Scotland, he launched his consulting career in 2002 with the founding of The Next Idea, a hospitality concept and design agency that has since evolved into The Next Idea Group. Under his leadership, the firm has overseen more than 800 restaurant and café openings, remodels, and brand launches across more than 24 countries. As a leading authority on food‑service concepts, franchising, architectural design, and emerging consumer behaviors, he also serves as Chairman of Heritage Restaurant Consultants and as a board advisor to the cutting‑edge AI‑powered experience platform Atmosfy.
A respected futurologist in hospitality, Robert produces annual trend forecasts that span robotics, AI, vegan and non-alcoholic beverages, and the shifting demise of traditional casual-dining brands, even predicting TGI Fridays’s struggles. In an exciting new publishing venture, he has launched a visionary trilogy of books debuting in Fall/Winter 2025. The first volume, Restaurant Marketing: The Ultimate Guide to Modern Restaurant Marketing, delivers a 250-plus-page playbook, combining AI, SEO, design psychology, loyalty programs, vendor directories, and real-world case studies, to help operators thrive in a tech-driven marketplace. Subsequent volumes will tackle restaurant design and the traveling restaurant consultant, offering both tactical guidance and behind‑the‑scenes stories drawn from his global career.
Websites
https://www.thenextideagroup.com
https://www.globaldesignconsultant.com
https://www.robertancill.com
https://www.Heritagerestaurantconsultants.com
https://www.linkedin.com/in/robertancill
Websites and Contact:
email: info@robertancill.com / text: 747 249 4320
Heritage Restaurant Consultants (street team)
GlobeNewswire (2025) — GLP-1 Market Forecast 2024–2035
UBS Global Research (2024) — GLP-1 Adoption Outlook
Restaurant Business (2024) — Protein on Menus
QSR Magazine (2024) — How GLP-1 is Shifting Dining Habits
Modern Restaurant Management (2025) — GLP-1s and Menus
Wasserstrom Blog (2025) — Adapting Menus for GLP-1 Customers
Axios (2025) — Anti-Obesity Drug Growth
References
- GlobeNewswire (2025) — GLP-1 Market Forecast 2024–2035
- UBS Global Research (2024) — GLP-1 Adoption Outlook
- Restaurant Business (2024) — Protein on Menus
- QSR Magazine (2024) — How GLP-1 is Shifting Dining Habits
- Modern Restaurant Management (2025) — GLP-1s and Menus
- Wasserstrom Blog (2025) — Adapting Menus for GLP-1 Customers
- Axios (2025) — Anti-Obesity Drug Growth